TrialScientific reports2024

A noninferiority randomized open-label pilot study of 3- versus 7-day influenza postexposure prophylaxis with oseltamivir in hospitalized children.

August Wrotek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.